5-78886027-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000046.5(ARSB):​c.899-200A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 152,004 control chromosomes in the GnomAD database, including 12,646 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 12646 hom., cov: 32)

Consequence

ARSB
NM_000046.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0690

Publications

12 publications found
Variant links:
Genes affected
ARSB (HGNC:714): (arylsulfatase B) Arylsulfatase B encoded by this gene belongs to the sulfatase family. The arylsulfatase B homodimer hydrolyzes sulfate groups of N-Acetyl-D-galactosamine, chondriotin sulfate, and dermatan sulfate. The protein is targeted to the lysozyme. Mucopolysaccharidosis type VI is an autosomal recessive lysosomal storage disorder resulting from a deficiency of arylsulfatase B. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Dec 2016]
ARSB Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-78886027-T-C is Benign according to our data. Variant chr5-78886027-T-C is described in ClinVar as Benign. ClinVar VariationId is 680475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.6 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000046.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARSB
NM_000046.5
MANE Select
c.899-200A>G
intron
N/ANP_000037.2
ARSB
NM_198709.3
c.899-200A>G
intron
N/ANP_942002.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARSB
ENST00000264914.10
TSL:1 MANE Select
c.899-200A>G
intron
N/AENSP00000264914.4
ARSB
ENST00000396151.7
TSL:1
c.899-200A>G
intron
N/AENSP00000379455.3
ARSB
ENST00000565165.2
TSL:1
c.899-200A>G
intron
N/AENSP00000456339.2

Frequencies

GnomAD3 genomes
AF:
0.402
AC:
61081
AN:
151886
Hom.:
12639
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.417
Gnomad AMI
AF:
0.383
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.396
Gnomad EAS
AF:
0.618
Gnomad SAS
AF:
0.572
Gnomad FIN
AF:
0.281
Gnomad MID
AF:
0.401
Gnomad NFE
AF:
0.377
Gnomad OTH
AF:
0.412
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.402
AC:
61134
AN:
152004
Hom.:
12646
Cov.:
32
AF XY:
0.400
AC XY:
29734
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.417
AC:
17280
AN:
41430
American (AMR)
AF:
0.431
AC:
6583
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
1372
AN:
3468
East Asian (EAS)
AF:
0.618
AC:
3188
AN:
5156
South Asian (SAS)
AF:
0.571
AC:
2749
AN:
4814
European-Finnish (FIN)
AF:
0.281
AC:
2976
AN:
10580
Middle Eastern (MID)
AF:
0.411
AC:
120
AN:
292
European-Non Finnish (NFE)
AF:
0.377
AC:
25647
AN:
67958
Other (OTH)
AF:
0.413
AC:
870
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1811
3621
5432
7242
9053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.389
Hom.:
17764
Bravo
AF:
0.409
Asia WGS
AF:
0.619
AC:
2153
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.6
DANN
Benign
0.36
PhyloP100
-0.069
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180049; hg19: chr5-78181850; API